NCT01197300View on ClinicalTrials.gov

1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids

PHASE3CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 25, 2010

Primary Completion Date

February 27, 2019

Study Completion Date

February 27, 2019

Conditions
Osteoporosis
Interventions
DRUG

Zoledronic acid

intravenous infusion

Trial Locations (10)

1085

Novartis Investigative Site, Budapest

2013

Novartis Investigative Site, Soweto

2145

Novartis Investigative Site, Westmead

119991

Novartis Investigative Site, Moscow

195067

Novartis Investigative Site, Saint Petersburg

V6H 3V4

Novartis Investigative Site, Vancouver

K1H 8L1

Novartis Investigative Site, Ottawa

H3H 1P3

Novartis Investigative Site, Montreal

H3T 1C5

Novartis Investigative Site, Montreal

B4 6NH

Novartis Investigative Site, West Midlands

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY